Distribution of cathepsin D granules in normal and pathologic conditions in human prostate

Acta Urologica Japonica

Volumn 48, Issue 11, 2002, Pages 647-652

  Islam, A H M Manjurul ^a   Kato, Haruaki ^a   Nishizawa, Osamu ^a   Hayama, Masayoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cathepsin D; Immunohistochemistry Apoptotic bodies; Prostate

Indexed keywords

CATHEPSIN D;

ADOLESCENT; ADULT; AGED; AGING; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; PREPUBERTY; PROSTATE CANCER; PROSTATE DISEASE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; APOPTOSIS; CATHEPSIN D; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0036866892     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Barrett AJ: Cathepsin D and other carboxyl proteinases. In: Proteinases in Mammalian Cells and Tissues. Edited by Barrett AJ, pp 209-248, North-Holland Biochemical Press, Amsterdam, 1977
2. Dean RT: Direct evidence of importance of lysosomes in degradation of intracellular protein. Nature 257: 414-416, 1975
3. Nishimura Y, Kawabata T, Yano S, et al.: Intracellular processing and secretion of lysosomal cathepsins. Acta Histochem Cytochem 23: 53-64, 1990
4. Rochefort H, Capony F and Gercia M: Cathepsin D in breast cancer: From molecular and cellular biology to clinical applications. Cancer Cells 2: 383-388, 1990
5. Leto G, Gebbia N, Rausa L, et al.: Cathepsin D in the malignant progression of neoplastic diseases (Review). Anticancer Res 12: 235-240, 1992
6. Maker R, Mason A, Kittelson JM, et al.: Immunohistochemical analysis of cathepsin D in prostate carcinoma. Mod Pathol 7: 747-751, 1994
7. Ross JS, Nazeer T, Figge HL, et al.: Quantitative immunohistochemical determination of cathepsin D levels in prostate carcinoma biopsies: Correlation with tumor grade, stage, PSA levels and DNA ploidy status. Am J Clin Pathol 104: 36-41, 1995
8. Whitaker JN and Rhodes RH: The distribution of cathepsin D in rat tissues determined by immunocytochemistry. Am J Anat 166: 417-428, 1983
9. Cherry JP, Mordente JA, Chapman JR, et al.: Analysis of cathepsin D forms and their clinical implications in human prostatic cancer. J Urol 160: 2223-2228, 1998
10. Sensiber JA, Liu X, Patai B, et al.: Characterization of castration-induced cell death in the rat prostate by immunohistochemical localization of cathepsin D. Prostate 16: 263-276, 1990
11. Lee C, Sensiber JA, Dudek SM, et al.: Prostatic ductal system in rats: Regional variation in morphological and functional activities. Biol Reprod 43: 1079-1086, 1990
12. Claus S, Berges R, Senge T, et al.: Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urol 158: 217-221, 1997
13. Claus S, Wrenger M, Senge T, et al.: Immunohistochemical determination of age-related proliferation rates in normal and bengin hyperplastic prostate. Urol Res 21: 305-308, 1993
14. Djonov V, Ball RV, Studer UR, et al.: Transforming growth factor β-3 expression correlates with cytoplasmic localization of androgen receptor and with cell death in normal prostate and benign prostatic hyperplasia. J Urol 56: 1394A, 1996
15. Maygarden ST, Novotny DB, Moul JW, et al.: Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7: 930-936, 1994